AstraZeneca PLC | NASDAQ:AZN - Fraywire Market Portal
⚡ Login to use Pulse AI
Simple Chart
Advanced Chart
Login for Volatility Chart


AstraZeneca PLC on Glideslope

News aggregated by Glideslope.ai
July 22, 2025
(RTTNews) - AstraZeneca Plc. (AZN.ST, ZEG.DE, AZN.L, AZN) announced a major investment of $50 billion in the United States by 2030. This move...
June 16, 2025
Investors in AstraZeneca plc (Symbol: AZN) saw new options become available today, for the December 19th expiration. One of the key data poi...
May 9, 2025
(RTTNews) - AstraZeneca Plc. (AZN, AZN.L) announced that results from the POTOMAC Phase III trial showed that one year of treatment with its ...
April 4, 2025
(RTTNews) - AstraZeneca Plc. (AZN.L, AZN) and Daiichi Sankyo's (DSKYF.PK) Enhertu (trastuzumab deruxtecan) has been approved in the Euro...
March 31, 2025
(RTTNews) - British drug major AstraZeneca Plc.'s (AZN, AZN.L) Imfinzi (durvalumab) in combination with gemcitabine and cisplatin as neo...
March 8, 2025
Below is Validea's guru fundamental report for ASTRAZENECA PLC (ADR) (AZN). Of the 22 guru strategies we follow, AZN rates highest usin...
March 1, 2025
Below is Validea's guru fundamental report for ASTRAZENECA PLC (ADR) (AZN). Of the 22 guru strategies we follow, AZN rates highest usin...
February 26, 2025
(RTTNews) - AstraZeneca plc (AZN, AZN.L), on Wednesday, reported positive high-level results from a planned interim analysis of the SERENA-6 ...